Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg

EMVERM Provides a New Option for Patients with Pinworm, Whipworm, Roundworm and Hookworm in Single or Mixed Infections HAYWARD, Calif., Jan. 15, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL) today announced that the ... Biopharmaceuticals, FDAImpax Laboratories, EMVERM, common roundworm, common hookworm
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news